[Video Profile] CoreSpine Technologies
CoreSpine Technologies is a Minneapolis, MN-based orthopedics company developing a device to prepare the spinal disc space prior to surgery. The company’s platform removes material […]
Profiles
[Video Profile] Interview with Michael Fons, VP Corporate Development at Inovio Biomedical
Inovio Biomedical’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based […]
Trod Medical: FDA 510(k) Clearance for Encage
Trod Medical has received FDA 510(k) clearance for Encage, a minimally invasive technology for soft tissue ablation. The surgical system allows for precise percutaneous ablation […]
Liquidity Crisis: Minrad International Slashes Jobs, Evaluates Options
In an effort to improve its cost structure and conserve cash, Minrad International said it would layoff 35 percent of its workforce, or some 50 […]
SyntheMed: FDA Clearance for SinusShield
SyntheMed, of Iselin, NJ, has received FDA 510(k) clearance for SinusShield, a bioresorbable membrane to prevent post-operative adhesions from forming after nasal and sinus surgeries. […]
[Video Profile] Interview with Eric Le Royer, CEO of EndoSense SA
Endosense is developing a catheter ablation treatment for cardiac rhythm disorders, including atrial fibrillation (AF). AF is the most common cardiac rhythm disorder today, affecting […]
Endocare and Galil Medical to Merge
Only months after Healthtronics withdrew its offer to acquire Endocare for $2.28 per share, Endocare and privately held Galil Medical have agreed to merge. The […]
[Video Interview] Richard Taney, President & CEO of Delcath Systems
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often […]
Cyberkinetics Neurotechnology Nearing Paralysis
In a recent filing, Cyberkinetics Neurotechnology said it only had enough cash to last 30 days. If negotiations fail with its secured creditor, GE Capital, […]
Symphony Medical Raises $10 Million
Symphony Medical, a privately-held company developing novel biocompatible polymer therapies to treat chronic heart failure and atrial fibrillation has raised $10 million in a Series […]